HLB SCIENCE Inc.
Develops innovative therapeutics and diagnostics for infectious and neurodegenerative diseases.
343090 | KO
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 송파구 법원로 128씨동 1314호, 서울특별시
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
HLB SCIENCE Inc. is a global biopharmaceutical company dedicated to developing innovative new drugs for infectious and immune-related diseases. The company's core pipeline focuses on critical unmet medical needs, including therapeutics for bacterial sepsis and infections caused by superbacteria. A key candidate, DD-S052P, is a novel antibiotic designed to neutralize both pathogens and the endotoxins they release. In the field of neurodegenerative diseases, HLB SCIENCE is advancing a treatment for Alzheimer's Disease, DD-A279, which modulates LPS and gram-negative bacteria, complemented by the DD-A514 diagnostic kit for early detection. The company leverages its expertise in life science and medicine to contribute to global health through its innovative therapeutic and diagnostic solutions.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for HLB SCIENCE Inc. and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
Automate Your Workflow. Get a real-time feed of all HLB SCIENCE Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for HLB SCIENCE Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
